IT8621393A1 - Composizioni farmaceutiche ad azione vasodilatatrice ed antianossica - Google Patents

Composizioni farmaceutiche ad azione vasodilatatrice ed antianossica

Info

Publication number
IT8621393A1
IT8621393A1 IT1986A21393A IT2139386A IT8621393A1 IT 8621393 A1 IT8621393 A1 IT 8621393A1 IT 1986A21393 A IT1986A21393 A IT 1986A21393A IT 2139386 A IT2139386 A IT 2139386A IT 8621393 A1 IT8621393 A1 IT 8621393A1
Authority
IT
Italy
Prior art keywords
antianoxic
vasodilating
action
pharmaceutical compositions
pharmaceutical
Prior art date
Application number
IT1986A21393A
Other languages
English (en)
Other versions
IT1197061B (it
IT8621393A0 (it
Original Assignee
Seuref Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seuref Ag filed Critical Seuref Ag
Publication of IT8621393A0 publication Critical patent/IT8621393A0/it
Publication of IT8621393A1 publication Critical patent/IT8621393A1/it
Application granted granted Critical
Publication of IT1197061B publication Critical patent/IT1197061B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT21393/86A 1985-08-02 1986-08-01 Composizioni farmaceutiche ad azione vasodilatatrice e antianossica IT1197061B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH3344/85A CH670763A5 (it) 1985-08-02 1985-08-02

Publications (3)

Publication Number Publication Date
IT8621393A0 IT8621393A0 (it) 1986-08-01
IT8621393A1 true IT8621393A1 (it) 1988-02-01
IT1197061B IT1197061B (it) 1988-11-25

Family

ID=4253937

Family Applications (1)

Application Number Title Priority Date Filing Date
IT21393/86A IT1197061B (it) 1985-08-02 1986-08-01 Composizioni farmaceutiche ad azione vasodilatatrice e antianossica

Country Status (9)

Country Link
US (1) US4778798A (it)
JP (1) JPS6253932A (it)
BE (2) BE905198A (it)
CH (1) CH670763A5 (it)
DE (1) DE3625877A1 (it)
FR (1) FR2591481B1 (it)
GB (1) GB2178314B (it)
IT (1) IT1197061B (it)
NL (1) NL8601977A (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH662505A5 (it) * 1985-04-30 1987-10-15 Seuref Ag Composizioni farmaceutiche ad azione protettiva vascolare.
US4871731A (en) * 1987-10-07 1989-10-03 Marion Laboratories, Inc. Captopril and diltiazem composition and the like
JPH02188523A (ja) * 1989-01-13 1990-07-24 M S C:Kk 睡眠時無呼吸症治療薬
DE3918082A1 (de) * 1989-06-02 1991-01-24 Max Planck Gesellschaft Mittel gegen autoimmunerkrankungen
FR2655854A1 (fr) * 1989-12-19 1991-06-21 Poissonnet Claude Medication nouvelle pour le traitement de surcharges lipidiques.
US5145859A (en) * 1991-03-20 1992-09-08 Case Western Reserve University Methods of treating interstitial cystitis and urethral syndrome
US6461593B1 (en) * 1992-02-19 2002-10-08 Biomedical And Clinical Research Therapy with coenzyme Q10 to reduce subgingival microorganisms in patients with periodontal disease
IT1265312B1 (it) * 1993-12-21 1996-10-31 Indena Spa Formulazioni contenenti carotenoidi e procarotenoidi associati a polifenoli nella prevenzione dei danni da abnorme produzione di
US20020032160A1 (en) * 1995-02-24 2002-03-14 Nyce Jonathan W. Compositions & formulations with an epiandrosterone or a ubiquinone & kits & their use for treatment of asthma symptoms & for reducing adenosine/adenosine receptor levels
US5660835A (en) * 1995-02-24 1997-08-26 East Carolina University Method of treating adenosine depletion
CA2272971C (en) * 1998-10-29 2008-01-15 Institut National De La Sante Et De La Recherche Medicale (Inserm) Quinone derivatives for treating or preventing diseases associated with iron overload
DE19928528C2 (de) * 1999-06-22 2002-10-17 Heinz Kiefer Arzneimittel (Antiarteriosklerotikum) zur Vorbeugung und Linderung von Beschwerden bei arteriellen Durchblutungsstörungen auf der Grundlage von Ginkgobiloba
GB2368012A (en) 2000-10-19 2002-04-24 Nicholas John Larkins Preparation for the relief of inflammatory disease
GB0209254D0 (en) * 2002-04-23 2002-06-05 Larkins Nicholas J Preparation for the relief of disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5938203B2 (ja) * 1976-04-26 1984-09-14 エーザイ株式会社 補酵素ｑを主成分とする脳循環障害治療剤
JPS5913710A (ja) * 1982-07-15 1984-01-24 Shiseido Co Ltd 養毛料
CH655005A5 (it) * 1983-02-16 1986-03-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare.

Also Published As

Publication number Publication date
CH670763A5 (it) 1989-07-14
GB2178314A (en) 1987-02-11
DE3625877A1 (de) 1987-02-05
IT1197061B (it) 1988-11-25
NL8601977A (nl) 1987-03-02
DE3625877C2 (it) 1992-04-02
FR2591481A1 (fr) 1987-06-19
JPS6253932A (ja) 1987-03-09
BE905198A (nl) 1986-11-17
IT8621393A0 (it) 1986-08-01
BE905211A (nl) 1987-02-04
FR2591481B1 (fr) 1992-05-29
GB8618249D0 (en) 1986-09-03
US4778798A (en) 1988-10-18
GB2178314B (en) 1990-02-21

Similar Documents

Publication Publication Date Title
BR1100036A (pt) Composto e composição farmacêutica
DK330287A (da) Antiinflammatorisk forbindelse og farmaceutisk sammensaetning indeholdende samme
IT1205010B (it) Tetraidronaftalin-derivati e indan-derivati
FI863708A0 (fi) Oraalinen hammaskiven muodostumista ehkäisevä koostumus
IT1191608B (it) Composizione farmaceutica e forme farmaceutiche che la contengono
DK151686D0 (da) Hydroxamater
KR870700608A (ko) 아미노-살리실산 유도체 및 제약 조성물
IT8621393A1 (it) Composizioni farmaceutiche ad azione vasodilatatrice ed antianossica
KR870700358A (ko) 약물제조방법 및 그 용도
DK470886A (da) Oxazol- og isoxazolderivater
IT1229176B (it) Antibiotici antitumorali bbm-1675c e d
IT1197811B (it) 2h-benzotriazoli 5-superiore alchil-sostituiti e composizioni stabilizzate
FR2576020B1 (fr) 5-halopyridine-3-carboxamides et leurs applications
DK488185A (da) N6-benzopyrano- og benzothiopyranoadenosiner
FR2584294B1 (fr) Compositions pharmaceutiques a visee cytotrophique
IT8547704A1 (it) Diazepinoindoli loro preparazione e loro impiego come medicamenti
IT1200467B (it) Formulazione farmaceutica
FR2588259B1 (fr) Bis-acridiniques monopontes et bis-acridiniques bipontes
IT1203737B (it) Composizioni farmaceutiche comprendenti 3-amminopropossi-indoli
IT1190383B (it) Sostanze peptidominetiche ad azione ipotensiva
FR2592379B1 (fr) Pyridine-3-carboxamides et leurs applications
BR1100961A (pt) Composto e composição farmacêutica
BR6500407U (pt) Composicao medicinal
IT8535592V0 (it) Custodia-scatola automontante ed autoriducibile
LV5789B4 (lv) Hinolinsakbes saturosas kompozicijas un tabletes